56.43
1.31 (2.38%)
| Previous Close | 55.12 |
| Volume | 61,242 |
| Price / Sales | 2.55 |
| Price / Book | 22.01 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.990 |
| Total Debt/Equity (MRQ) | 7.24% |
| Current Ratio (MRQ) | 15.58 |
| Operating Cash Flow (TTM) | -40.08 M |
| Levered Free Cash Flow (TTM) | -19.59 M |
| Return on Assets (TTM) | -43.61% |
| Return on Equity (TTM) | -77.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Pulse Biosciences, Inc | Mixed | Mixed |
AIStockmoo Score
| Value 35% | 0.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | 0.0 |
| Timing 35% | 0.8 |
| AI Technical info | NA |
| Technical Oscillators info | 2.0 |
| Technical Moving Averages info | -1.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×0.90 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | +5.5% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | -2.8 |
| Final Score | 0.25 |
Select this tab to load the latest available analysis.
|
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 74.00% |
| % Held by Institutions | 8.62% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |